JPRN-UMIN000033956已完成4 期
To compare safety and efficacy of topical Tacrolimus (0.03%) and dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis. - Tacro vs Dexa for subepithelial infiltrates.
aser Eye Clinic Noida0 个研究点目标入组 90 人开始时间: 2018年8月31日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
9
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 75years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who received any topical or systemic medications, had ocular disease like uveitis, glaucoma, or active keratitis, used corticosteroid eye drops; and those who had any ocular operations were excluded from the study.
研究者
相似试验
终止
不适用
Tacrolimus Ointment in Oral Lichen PlanusOral Lichen PlanusNCT01544842University of Oulu28
已完成
1 期
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host DiseaseOcular GVHDNCT01977781Massachusetts Eye and Ear Infirmary40
已完成
1 期
Safety and efficacy of topical tacrolimus therapy for refractory pouchitispouchitisJPRN-UMIN000006658Department of lower gastroenterological surgery, Hyogo college of Medicine10
已完成
2 期
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)Cutaneous Lupus ErythematosusNCT00317681Heinrich-Heine University, Duesseldorf30
招募中
4 期
To compare the effect of tacrolimus and pimecrolimus in white patch patientsCTRI/2014/08/004882TANVI SINGH BHADORIA60
